NM_018297.4:c.1508G>A

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS1

The NM_018297.4(NGLY1):​c.1508G>A​(p.Arg503His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000266 in 1,554,868 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R503G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0014 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00015 ( 0 hom. )

Consequence

NGLY1
NM_018297.4 missense

Scores

19

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.305

Publications

2 publications found
Variant links:
Genes affected
NGLY1 (HGNC:17646): (N-glycanase 1) This gene encodes an enzyme that catalyzes hydrolysis of an N(4)-(acetyl-beta-D-glucosaminyl) asparagine residue to N-acetyl-beta-D-glucosaminylamine and a peptide containing an aspartate residue. The encoded enzyme may play a role in the proteasome-mediated degradation of misfolded glycoproteins. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2009]
NGLY1 Gene-Disease associations (from GenCC):
  • congenital disorder of deglycosylation 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • NGLY1-deficiency
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0040923357).
BP6
Variant 3-25729236-C-T is Benign according to our data. Variant chr3-25729236-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 541259.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00137 (209/152134) while in subpopulation AFR AF = 0.00491 (204/41510). AF 95% confidence interval is 0.00436. There are 1 homozygotes in GnomAd4. There are 109 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NGLY1NM_018297.4 linkc.1508G>A p.Arg503His missense_variant Exon 10 of 12 ENST00000280700.10 NP_060767.2 Q96IV0-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NGLY1ENST00000280700.10 linkc.1508G>A p.Arg503His missense_variant Exon 10 of 12 1 NM_018297.4 ENSP00000280700.5 Q96IV0-1

Frequencies

GnomAD3 genomes
AF:
0.00136
AC:
207
AN:
152016
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00488
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000197
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000309
AC:
71
AN:
230070
AF XY:
0.000263
show subpopulations
Gnomad AFR exome
AF:
0.00440
Gnomad AMR exome
AF:
0.000236
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000371
GnomAD4 exome
AF:
0.000146
AC:
205
AN:
1402734
Hom.:
0
Cov.:
29
AF XY:
0.000139
AC XY:
97
AN XY:
697058
show subpopulations
African (AFR)
AF:
0.00485
AC:
152
AN:
31310
American (AMR)
AF:
0.000270
AC:
11
AN:
40782
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24512
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37182
South Asian (SAS)
AF:
0.0000520
AC:
4
AN:
76964
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51102
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5564
European-Non Finnish (NFE)
AF:
0.0000130
AC:
14
AN:
1078012
Other (OTH)
AF:
0.000419
AC:
24
AN:
57306
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
11
22
32
43
54
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00137
AC:
209
AN:
152134
Hom.:
1
Cov.:
32
AF XY:
0.00147
AC XY:
109
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.00491
AC:
204
AN:
41510
American (AMR)
AF:
0.000196
AC:
3
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10584
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
67964
Other (OTH)
AF:
0.000473
AC:
1
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
9
17
26
34
43
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000547
Hom.:
2
Bravo
AF:
0.00159
ESP6500AA
AF:
0.00704
AC:
31
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000511
AC:
62
Asia WGS
AF:
0.000578
AC:
2
AN:
3476

ClinVar

Significance: Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 22, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 25344691) -

Nov 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NGLY1: BP4 -

Congenital disorder of deglycosylation Benign:1
Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.054
BayesDel_addAF
Benign
-0.68
T
BayesDel_noAF
Benign
-0.75
CADD
Benign
7.2
DANN
Benign
0.79
DEOGEN2
Benign
0.084
.;T;.;T;.
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.6
FATHMM_MKL
Benign
0.027
N
LIST_S2
Benign
0.60
T;T;T;T;T
M_CAP
Benign
0.0063
T
MetaRNN
Benign
0.0041
T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.35
.;N;N;.;.
PhyloP100
-0.30
PrimateAI
Benign
0.18
T
PROVEAN
Benign
-0.70
N;N;N;N;N
REVEL
Benign
0.069
Sift
Benign
0.23
T;T;T;T;T
Sift4G
Benign
0.29
T;T;T;T;T
Polyphen
0.0
B;B;B;.;.
Vest4
0.055
MVP
0.15
MPC
0.041
ClinPred
0.0042
T
GERP RS
-10
Varity_R
0.016
gMVP
0.32
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs139134926; hg19: chr3-25770727; COSMIC: COSV54983772; API